![Laurie Doyle](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Laurie Doyle
Investor Relations Kontakt bei GPC Biotech, Inc.
Ursprung des Netzwerks ersten Grades von Laurie Doyle
Einheit | Art der Einheit | Industrie | |
---|---|---|---|
GPC Biotech, Inc.
![]() GPC Biotech, Inc. Drugstore ChainsRetail Trade GPC Biotech, Inc. discovers and develops anticancer drugs through discovery technologies and development approaches. It is a mechanism-based drug discovery and development company focused on treatments for cancer and fungal infections. The company is a wholly owned subsidiary of GPC Biotech AG. GPC Biotech was founded in 1992 and is located in Waltham, MA.
2
| Subsidiary | Drugstore Chains | 2 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von Laurie Doyle
Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
---|---|---|---|
Harvard University
![]() Harvard University Other Consumer ServicesConsumer Services Harvard University engages in the provision of teaching and research. It has twelve degree-granting Schools in addition to the Radcliffe Institute for Advanced Study, offering a global education. The university was founded in 1636 and is headquartered in Cambridge, MA. | College/University | Corporate Officer/Principal | |
DuPont Pharmaceuticals Co.
![]() DuPont Pharmaceuticals Co. Pharmaceuticals: MajorHealth Technology DuPont Pharmaceuticals Co. researches and develops pharmaceuticals and imaging products to treat diseases. It focuses on pharmaceuticals to treat unmet medical needs in the fight against HIV, cardiovascular disease, central nervous system disorders, cancer and arthritis-related disorders. The company is located in Wilmington, DE. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Neuron Corp.
![]() Neuron Corp. Industrial MachineryProducer Manufacturing Part of Ai Holdings Corp., Neuron Corp. is a Japanese company that provides services to enable pilotless flights, from drone deliveries and search and rescue, to air taxis and cargo deliveries. The private company is based in Yokohama, Japan. Neuron, formerly espace networks, is a connectivity management platform for things that move, such as ships, planes and trains. Neuron was acquired by Ai Holdings Corp. from TB Group, Inc. on July 01, 2008 for $1.98 million. | Industrial Machinery | Corporate Officer/Principal | |
Massachusetts Institute of Technology | College/University | Doctorate Degree | |
University of London | College/University | Doctorate Degree | |
Immatics Biotechnologies GmbH
![]() Immatics Biotechnologies GmbH Pharmaceuticals: MajorHealth Technology Immatics Biotechnologies GmbH operates as a biopharmaceutical company that develops anti-cancer immunotherapy products. The firm specializes in the discovery and development of immunotherapy products against cancer. It develops IMA901, a combination of multiple tumor-associated peptides (TUMAPs) for the treatment of renal cell carcinoma. The company was founded by Harpreet Singh, Toni Weinschenk, Niels Emmerich, Hans Georg Rammensee, Hansjörg Schild, and Peter Brossart in 2000 and is headquartered in Tübingen, Germany. | Pharmaceuticals: Major | Director/Board Member | |
University College London | College/University | Undergraduate Degree | |
Promedior, Inc.
![]() Promedior, Inc. Medical SpecialtiesHealth Technology Promedior, Inc. is a clinical-stage immunotherapy company, which engages in the development of targeted therapeutics to treat fibrotic diseases. Its proprietary therapeutic platform is based upon Pentraxin-2, an endogenous human protein that plays an important role in regulating the response to fibrosis. The company was founded by Gomer H. Richard, Lawrence M. Kauvar, and Darrell Pilling in April 2006 and is headquartered in Lexington, MA. | Medical Specialties | Corporate Officer/Principal | |
Prosalix GmbH | Chief Executive Officer | ||
iOmx Therapeutics AG
![]() iOmx Therapeutics AG BiotechnologyHealth Technology iOmx Therapeutics AG develops immunotherapy treatments for cancer patients. It specializes in immuno oncology, drug development and cancer therapy. The company was founded by Nisit Khandelwal, Philipp Beckhove, Patrick Baeuerle, Sebastian Meier-Ewert and Elmar Maier in March 2016 and is headquartered in Munich, Germany. | Biotechnology | Chief Executive Officer |
Statistik
International
Deutschland | 7 |
Vereinigte Staaten | 6 |
Vereinigtes Königreich | 3 |
Japan | 2 |
Sektoral
Health Technology | 7 |
Consumer Services | 4 |
Finance | 3 |
Commercial Services | 2 |
Producer Manufacturing | 2 |
Operativ
Corporate Officer/Principal | 5 |
Chief Executive Officer | 4 |
Founder | 3 |
Doctorate Degree | 2 |
Director/Board Member | 2 |
Am stärksten vernetzte Beziehungen
- Börse
- Insiders
- Laurie Doyle
- Unternehmensverbindungen